Phase IIa trial of dipraglurant in the treatment of focal cervical dystonia

Trial Profile

Phase IIa trial of dipraglurant in the treatment of focal cervical dystonia

Planning
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2016

At a glance

  • Drugs Dipraglurant (Primary)
  • Indications Torticollis
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 17 Oct 2016 According to an Addex Therapeutics media release, anticipates the availability of data in the second half of 2017.
    • 17 Oct 2016 According to an Addex Therapeutics media release, Buz Jinnah, Director of the Dystonia Coalition and Professor of Neurology at Emory University, will serve as the lead investigator.
    • 17 Oct 2016 According to an Addex Therapeutics media release, this trial is expected to initiate in the fourth quarter of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top